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Abstract
Study Design: Narrative review.
Objectives: To discuss the importance of establishing diagnostic criteria in Degenerative Cervical Myelopathy (DCM), including
factors that must be taken into account and challenges that must be overcome in this process.
Methods: Literature review summarising current evidence of establishing diagnostic criteria for DCM.
Results: Degenerative Cervical Myelopathy (DCM) is characterised by a degenerative process of the cervical spine resulting in
chronic spinal cord dysfunction and subsequent neurological disability. Diagnostic delays lead to progressive neurological decline
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with associated reduction in quality of life for patients. Surgical decompression may halt neurologic worsening and, in many cases,
improves function. Therefore, making a prompt diagnosis of DCM in order to facilitate early surgical intervention is a clinical
priority in DCM.
Conclusion: There are often extensive delays in the diagnosis of DCM. Presently, no single set of diagnostic criteria exists for
DCM, making it challenging for clinicians to make the diagnosis. Earlier diagnosis and subsequent specialist referral could lead to
improved patient outcomes using existing treatment modalities.
Keywords
degenerative, cervical, spine, myelopathy, diagnostic, criteria

Introduction
Degenerative Cervical Myelopathy (DCM) is a condition characterised by degenerative changes in the cervical spine including osteophyte formation, ligament hypertrophy and
ossification, and intervertebral disc protrusion, resulting in
compression and eventual dysfunction of the cervical spinal
cord.1-3 DCM causes progressive neurological symptoms,
functional disability for patients, and has a significant impact
on quality of life.4 Diagnosis of DCM is often delayed and
disease progression and functional deterioration can occur during this delay.5,6 Surgical decompression of the cervical spinal
cord may result in the relief of neurological symptoms, reduction of functional disability, and improvement in quality of
life.7-10 However, optimal surgical outcomes are achieved with
timely intervention, as a prolonged duration of pre-operative
symptoms has been associated with poorer post-operative functional outcomes.11-15 Improving early diagnosis and surgical
consideration for treatment is therefore critical in improving
long-term outcomes for DCM patients.16
The need for an early diagnosis and intervention is a key
theme behind many of the top research priorities identified by
the AO Spine RECODE-DCM (aospine.org/recode) [REsearch
objectives and COmmon Data Elements for DCM] research
priority setting process. AO Spine RECODE-DCM is an international consensus initiative, which aims to accelerate knowledge discovery that can improve outcomes, by developing a set
of research tools.17 It included a James Lind Alliance research
priority setting partnership, which brought together individuals
working on and individuals living with DCM, to establish the
most important unanswered questions. Research prioritization
aims to catalyze progress by consolidating resources on key
knowledge gaps. Establishing a diagnostic framework for
DCM emerged as the number 3 priority.
Unfortunately, at present, there are no established diagnostic
criteria for DCM.18,19 The most widely used scoring systems
for DCM, the Japanese Orthopaedic Association (JOA) and
modified JOA (mJOA), categorise severity of DCM rather than
provide diagnostic criteria.20 For this reason, they are useful for
tracking disease progression but not in establishing initial
diagnosis.
This article will outline the potential benefits to DCM care
and research of forming diagnostic criteria. Further, it will
summarise the current approach to diagnosing DCM and

reference how other fields have established diagnostic criteria
to explore how such approaches could occur in DCM. Further,
it will highlight factors that must be taken into account and
challenges that must be overcome.

How could Diagnostic Criteria Help DCM?
The pathway to establishing a diagnosis of DCM is heterogeneous and lengthy. Two recent studies examined the route that
patients took before being diagnosed with DCM and both have
demonstrated significant delays in diagnosis and referral to a
spinal surgeon.5,6 One of these studies identified that 43.1%
and 35.7% of the patients eventually diagnosed with DCM
were initially diagnosed in primary care as having carpal tunnel
syndrome or cervical disc radiculopathy without neurological
deficit respectively.5 This highlights the challenges in diagnosing DCM in primary care.
Patients typically first present in the primary care setting
before referral to a secondary care triage point; which can
include specialist services such as neurology, pain management, rheumatology, geriatrics, and general orthopaedics.
Those receiving a diagnosis of DCM are then referred onward
to a spine surgeon. This multi-staged referral pathway, often
interconnected by additional investigations, means access to
spinal surgery takes many months and sometimes years.
Furthermore, patients often experience inconsistent clinical
examinations throughout this pathway,21 adding to the current
complexity in reaching a diagnosis of DCM. The combination
of lack of a streamlined pathway and unclear diagnostic criteria
result in lengthy delays that may limit the effectiveness of
surgery, decrease potential postoperative improvement and
increase lifelong disability. Therefore, earlier diagnosis and
streamlining patients’ pathway of care in DCM must be made
in order to ensure timely diagnosis and effective management.
Potentially, definitive diagnostic criteria could accelerate this
process resulting in improved patient outcomes.
First and foremost, diagnostic criteria would act as a reference tool for Primary care physicians (PCPs) and musculoskeletal physiotherapists and improve the referral process. The use
of pre-imaging diagnostic likelihood is well established in
other diseases such as the Wells’ Score used in diagnosis of
Pulmonary Embolus,22 These criteria have reduced unnecessary imaging as well as improved the triage of high-risk
patients. The same principle could apply to DCM. A clear, and
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easy-to-apply pre-imaging diagnostic likelihood criteria could
help increase diagnostic confidence in PCPs raising the possibility of an underlying diagnosis of DCM early. These criteria
could be also included in any patient referral to secondary or
tertiary care to facilitate appropriate triage speed for clinical
review and early access to cervical spine MRI, given the timesensitive nature of a DCM diagnosis.
Second, diagnostic criteria could play a central role in the
creation of time-dependent standards of care in a DCM
patient’s journey. Diagnostic criteria, or even likelihood stratification, in primary care could serve as an initial trigger to
access urgent MRI investigation. For example, if a patient were
identified as having a high clinical likelihood of having DCM
in primary care by meeting certain criteria, a short time frame
could be set as the target within which the patient should
undergo an MRI scan to either confirm or refute the diagnosis
of DCM. Furthermore, if cervical spinal cord compression is
confirmed in the context of clinical myelopathy, therefore
meeting full diagnostic criteria, a further time frame target can
be applied to accelerate the specialist review and consultation
of these patients by a spinal surgeon or multidisciplinary team
service. A healthcare service’s ability to meet such target time
frames could then serve as the basis for logistical and financial
restructuring of services in a way to facilitate better care for
DCM patients through earlier access to imaging and specialist
review. Integration of a streamlined service could increase
benefits throughout the care pathway, which typically operates
on a first come first served basis, without specific triaging
based on case urgency.6
Third, if diagnostic criteria were established on an international level, research in DCM could be globally focussed. At
present, studies do not have a consistent definition of DCM and
thus whilst researchers must work on the assumption that study
participants are equal and accurately diagnosed. However, lack
of formal diagnostic criteria introduces the possibility of misdiagnosis, selection bias, and participant heterogeneity into
studies. This inherently undermines the statistical power and
conclusions of such studies. There has been a recent international push to recognise this issue and to standardise research
definitions and methodologies to facilitate inter-study comparability and meta-analysis,17 Diagnostic criteria would add further standardisation to this existing body of work and allow
clear research into clinical presentations of DCM as well as to
clarify patient pathways through healthcare systems.
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often subtle and perhaps transient, adding to the difficulty of
early diagnosis,1 Common patient complaints include hand
numbness, upper extremity weakness, bilateral arm paraesthesia, neck pain and stiffness, L’Hermitte’s sign, impaired gait,
and urgency of urination or defecation,23 Furthermore, the natural history of DCM is highly variable and not well defined.
Select few patients with DCM may experience rapid disease
progression, with the majority having a slow stepwise decline
in neurological function with often even long periods of stability. Given this heterogeneity, details about a patient’s disease
course alone may be less helpful in arriving at the correct
diagnosis.

Clinical Signs
A comprehensive neurological examination is beneficial to
identify and localize problems of the nervous system and to
begin to exclude other conditions. Patients with DCM often
present with bilateral, but not necessarily symmetrical, motor
and/or sensory deficits of the upper and lower extremities without facial involvement, alongside upper and/or lower motor
neuron signs. Upper motor neuron signs include hyperreflexia,
a Hoffmann’s sign, finger escape sign, plantar flexion
responses, lower limb spasticity, corticospinal distribution
motor deficits and weakness. Specific examples of hyperreflexia include the inverted supinator jerk, scapulohumeral
reflex, and the pectoralis reflex. In addition to upper motor
neuron signs caused by spinal cord compression, DCM patients
may concurrently present with lower motor signs resulting
from compression of cervical nerve roots as they exit the spinal
canal. These signs commonly include atrophy of intrinsic hand
muscles, fasciculations, and weakness that must be differentiated from other conditions such as amyotrophic lateral
sclerosis.
A systematic review by Cook et al (2011) evaluated the
diagnostic accuracy of various clinical signs in DCM by summarizing studies that reported on their sensitivity, specificity,
and positive and negative likelihood ratios24 (Table 1). Unfortunately, only a single study was rated as high quality evidence,25 This study reported that the test with the highest
sensitivity was the inverted supinator sign (61%), followed
by the suprapatellar tendon reflex (56%) and the Hoffmann’s
sign (44%). Although the presence of clonus and a Babinski
sign were not sensitive findings, they were the most specific
tests (92% and 96%, respectively) for DCM.

Overview of the Current Diagnosis and Assessment
of Degenerative Cervical Myelopathy Symptomatology

Diagnostic Imaging

The appropriate steps to diagnosing a patient with DCM
include obtaining a detailed medical history, performing a
comprehensive neurological examination, ordering appropriate
tests including imaging of the spinal axis, and formulating a
differential diagnosis. As DCM results from compression of the
cervical spinal cord, patients can present with a wide range of
symptoms in their upper and lower extremities as well as evidence of autonomic dysfunction. At an early stage these are

If DCM is suspected from a patient’s history and physical
examination, the next step is to obtain imaging of the cervical
spinal cord and vertebral column. Plain radiographs and computed tomography (CT) scans can help to assess bone quality,
disc spaces, spinal alignment, spondylolisthesis, cervical
instability, bony abnormalities including congenital canal stenosis, and ligamentous ossification.26,27 However, neither plain
radiographs nor CT scans can visualise intradural processes,
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Table 1. The Diagnostic Accuracy of Clinical Signs of DCM.
Pathological sign

Description

Positive test

Hoffmann’s Sign

The examiner stabilizes the proximal interphalangeal Flexion and adduction of the thumb and
joint of the middle finger and flicks the fingernail
concurrent flexion of the index finger
downwards

Inverted Supinator The examiner gently stimulates the distal
Sign
brachioradialis tendon with a reflex hammer

Finger Escape Sign

The examiner asks a patient to flex both elbows
to 90 degrees at his or her side, pronate the
forearms and adduct all fingers
Suprapatellar
The examiner stimulates the suprapatellar
Quadriceps Test
tendon of the quadriceps

Babinski Sign

The examiner applies a dull stimulus from the lateral
aspect of the plantar surface of the foot from the
heel to the ball and then medially across

Pectoralis Reflex
Biceps or Triceps
Hyperreflexia

The examiner stimulates the pectoralis tendon in the
deltopectoral groove with a reflex hammer
The examiner stimulates the biceps or triceps tendon
with a reflex hammer

Ankle
Hyperreflexia

The examiner stimulates the Achille’s tendon with
a reflex hammer

Quadriceps
Hyperreflexia

The examiner stimulates the patellar tendon with
a reflex hammer.

Clonus

The examiner applies a quick stretch to the Achilles
tendon with rapid dorsiflexion of the ankle

Romberg’s Sign

The examiner instructs a patient to stand with his
or her feet together with eyes closed and arms
at his or her side
The examiner observes a patient’s gait from
different angles

Gait

intramedullary lesions, nerve root entrapment, or cord compression and are therefore less useful for diagnostic purposes
in DCM. The gold standard for diagnosing DCM is magnetic
resonance imaging (MRI) as it can visualize neural, soft-tissue
and bony structures, quantify the degree of spinal canal stenosis
and cord compression, and identify intramedullary signal
change.28,29 MRI should be considered to assess any patient
with consistent clinical history, symptoms and signs of DCM.
This imaging should take place as a matter of priority given the
time-dependent deterioration in DCM. Full details of the role of
imaging in DCM can be found in a later article in this Special

Sensitivity, specificity,
LRþ, LR-

Sensitivity: 0-94%
Specificity: 0-90%
LRþ: 0-4.9
LR-: 0-1.01
Hyperactive finger flexion
Sensitivity: 18-61%
Specificity: 72-99%
LRþ: 2.6-29.1
LR-: 0.5-0.82
Inability of the patient to maintain
Sensitivity: 55%
adduction of the 5th digit which will start Specificity: 100%
to drift in an ulnar and volar direction
Hyperreflexive knee extension or hip
Sensitivity: 22-56%
flexion
Specificity: 33-97%
LRþ: 0.8-6.9
LR-: 0.81-1.3
Extension of the big toe with fanning
Sensitivity: 7-53%
of the second through fifth toes
Specificity: 92-100%
LRþ: 4.0-inf
LR-: 0.7-0.93
Hyperreflexive shoulder adduction
Not assessed
and internal rotation
Hyperreflexive flexion or extension at elbow Sensitivity: 18-44%
Specificity: 71-96%
LRþ: 1.5-4.8
LR-: 0.8-0.85
Hyperreflexive plantarflexion
Sensitivity: 15-26%
Specificity: 81-98%
LRþ: 1.37-7.8
LR-: 0.87-0.91
Hyperreflexive knee extension
Sensitivity: 33-94%
Specificity: 76%
LRþ: 1.37
LR-: 0.88
Ankle beats in and out of dorsiflexion
Sensitivity: 7-35%
for at least 3 beats
Specificity: 96-100%
LRþ: 2.7-inf
LR-: 0.87-0.94
Disruption in balance
Specificity: 100%

Ataxia, wide-based or spastic gait

Sensitivity: 19%
Specificity: 94%
LRþ: 3.4
LR-: 0.85

Edition of Global Spine Journal, Imaging and Neurophysiology
of DCM.

How are Diagnostic Criteria Formed?
Diagnostic criteria are essential to facilitate the definition, classification, standardisation, and further investigation of any disease. In its simplest form, diagnostic criteria may be comprised
of a single gold standard investigation, for example, a diagnosis
of HIV infection may be based solely upon a positive HIV
test.30 However, in most cases, a more complex and nuanced
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set of criteria is required. Ideally, such criteria should be valid,
reliable, and hold real-world applicability.
Validity is the degree to which data collected reflect a true
value (i.e. the accuracy of diagnostic criteria). In differentiating
between “diseased” and “non-diseased” patients, validity can
be measured by sensitivity and specificity. Sensitivity is the
percentage of diseased cases that a set of diagnostic criteria
defines as positive. Specificity is the percentage of nondiseased cases that a set of diagnostic criteria defines as negative. Ideally both should be high to ensure that no illness is
missed and no one is falsely diagnosed, but this can prove
challenging due to sensitivity and specificity often having an
inverse relationship. Therefore, most criteria must strike a compromise between the two properties. A receiver operating characteristic (ROC) curve plotting sensitivity vs. lack of
specificity can be used to determine a key threshold to optimise
this compromise.
Reliability is the extent to which repeated measurements get
similar results (i.e. precision or reproducibility). This can be
measured as the degree of dispersal of repeated measurements,
calculated as variance or standard deviation.31 In other words,
diagnostic criteria should be able to consistently yield the same
outcomes.
Any diagnostic criteria that are established as both valid and
reliable must also carry real-world reasonable applicability. For
example in acute stroke, Computer Tomography (CT) imaging
is favoured as a diagnostic tool instead of Magnetic Resonance
Imaging (MRI) because it is cheaper, quicker, and easier to
operate out of hours, even though MRI provides better detection of posterior lesions.32

Approaches to Developing Diagnostic Criteria
Diagnostic criteria can be developed in several ways. One of
the simplest methods is expert opinion providing a consensus
guideline. For example, in 2004, Graus et al. proposed a diagnostic criteria for paraneoplastic syndromes which involved an
international panel of neurologists reviewing existing practice
and, using their expertise, forming a unifying guideline.33 The
benefits of expert opinion include the incorporation of practical, clinical, as well as academic considerations in diagnosing a
condition as well as specialised knowledge of rare presentations and up-to-date real-world treatment options. However,
expert consensus opinion alone lacks comprehensive literature
review, possibly does not involve multidisciplinary input from
all stakeholders, and is overall a less rigorous development of
diagnostic criteria.34 Ultimately, expert opinion by itself can
only provide level 5 evidence.35
Another method used to develop diagnostic criteria is retrospective analysis. A list of potential individual diagnostic tests
are selected by an expert panel and then applied to a test population with the specific disease or condition as well as a control group without disease. The tests that are able to best detect
disease are then selected. For example, in the development of
the Diagnosis of Transient-Ischaemic Attack (TIA) (DOT)
score, multiple neurological symptoms and signs were
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analysed via a backward logistic regression model to identify
the most appropriate symptoms and signs to use.36 Multiple
potential diagnostic criteria can be compared simultaneously.
Overall, retrospective analysis is a more stringent and objective
methodology than expert opinion, while still relatively quick
and practical.
To improve the validity of both expert opinion and retrospective analysis, a prospective study can be carried out.
A prospective validation is where subjects are diagnosed with
the disease using the criteria in question and then followed up.
A positive predictive value is then calculated for the test. This
is useful for comparing different diagnostic criteria simultaneously. One example of this approach has been the prospective
evaluation of three diagnostic criteria for Disseminated Intravascular Coagulation.37 This method is systematic and provides validation for existing criteria. However, prospective
validation is more time consuming, expensive, and patients
may be lost to follow-up.
Smaller studies can also be compared together using a metaanalysis. For example, in 2012, Costa et al. compared the Awaji
criteria and the El Escorial diagnostic criteria for Amyotrophic
Lateral Sclerosis by analysing 8 studies, enrolling a total of
1187 patients.38 The advantages of meta-analysis include a
systematic review of existing literature as well as a larger and
more collated sample size meaning increased study power
improving validity and reliability of proposed criteria. On the
other hand, meta-analysis is an observational study and while
useful to generate potential criteria to be tested by new prospective studies, the data collected should be clinically applied
with caution, at least initially. New issues can be introduced
such as publication and selection bias.39
It is also noteworthy to mention that diagnostic criteria need
not include a single set of conditions to be met for a diagnosis
to be made. For example, the McDonald criteria widely used in
Multiple Sclerosis sets multiple possible iterations of clinical
and radiographic criteria of which only a single variation need
be met for a diagnosis to be made.40 Another example is that of
infective endocarditis, for which the modified Duke’s criteria
includes both major and minor criterion.41 This weighting of
criterion allows appropriate emphasis towards those
features that maximise a criteria’s validity, reliability, and
sustainability.

What Usability Factors Would Need to be Considered
in Creating Diagnostic Criteria for DCM?
As with any criteria, ease of use must be highly considered,
since success is based on usage. PCPs have high volume clinics
leading to short clinic appointments, with a mean duration in
the UK of 9.22 minutes.42 This short duration imposes challenges to performing an extensive neurological examination
alongside a detailed history taking that must accurately translate a patient’s ‘presenting complaint’ into an accurate medical
symptomatology. For example, a patient may present with
lethargy and gait difficulties. The burden is now upon the PCP
to distil the reasoning for this: shortness of breath as in
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cardiorespiratory disease, intermittent claudication as in vascular disease, or perhaps gait disturbance and lower limb sensory
dysfunction as in DCM, among many other possible causes. As
such, any diagnostic criteria for DCM would need to be reasonably applied to both clinical history and examination in a short
time frame whilst not losing undue sensitivity and specificity.
A further challenge is access to specialist imaging from
primary care. Globally, direct access from primary care to
specialist imaging such as MRI is limited and variable. Furthermore, even where it is available, PCPs may not be aware of this
availability or the optimal triage of patients.43 However, use of
clear guidelines and training for PCPs has been shown to
increase appropriate MRI referrals and lead to higher rates of
specialist intervention.44
A further consideration is the role of musculoskeletal services in the diagnosis of DCM. Such services would have more
experience and expertise in the detection of DCM and could be
used as an initial triaging step to avoid overburdening secondary and tertiary specialist services. As early diagnosis and
prompt treatment is important, urgent access pathways could
also be considered. ‘Red flag’ symptoms could be used as
criteria for an urgent referral system or for access to urgent
imaging. This could work in a similar way to the already established paradigm in clinicians’ minds of ‘red flag’ symptoms of
Cauda Equina Syndrome necessitating emergency MRI imaging.45 The key difference here would be that in DCM, urgent,
rather than emergency, imaging would be the response to ‘red
flag’ symptoms or signs of DCM. This could work in a similar
way to the UK’s National Health Service ‘Two Week Wait’
referral pathway for suspected malignancy. In this system, certain combinations of symptoms, signs, and laboratory findings
trigger clinical review by specialists or further investigations
within the following two weeks, hence the name. Frequent use
of such referral pathways has been associated with lower mortality for some malignancies, likely linked to more timely diagnosis and intervention at earlier stages of the disease.46

What Factors Could Diagnostic Criteria for DCM
Include?
Any proposed diagnostic criteria for DCM should consider the
inclusion of symptoms, neurological signs, and imaging findings. Other factors such as newly appreciated symptomatology
in DCM, duration and progression of symptoms, and demographic features may also offer improved sensitivity and specificity with their inclusion.47 One possibility would be to
design two sets of criteria: a pre-imaging diagnostic likelihood
criteria and post-imaging diagnostic confirmation criteria.
A pre-imaging criteria could be used in a similar manner to
the Wells’ criteria for pulmonary embolism to aid clinical decision making and to streamline referral for urgent imaging in
cases of high probability of DCM.22 Although it likely could
not be used as a definitive rule-out criteria, low probability
scores could be used to trigger re-consideration of the diagnosis
and perhaps drive other testing to investigate for a more likely
alternative diagnosis. Ultimately, effective criteria must be
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easily applicable in a time-pressured, non-specialist setting and
thus must strike a balance between maximising validity whilst
not unduly impacting clinician usability.

Symptoms
Upper extremity motor or sensory symptoms can be seen in a
wide variety of neurological diseases, including amyotrophic
lateral sclerosis, cervical radiculopathy, brachial plexopathy
and peripheral neuropathy. Symptoms of DCM are more likely
to present bilaterally (although not necessarily symmetrically),
reflect neurological dysfunction of the spinal cord (and hence
do not typically include bulbar or cortical symptoms), and
generally have a more insidious onset (rather than acute or
sub-acute in conditions such as cauda equina syndrome or
spinal cord infarction). Pre-imaging diagnostic criteria could
reflect this through positive and negative point scoring, as seen
in the ROSIER scoring system in Stroke.48

Neurological Signs
Patients with DCM often present with a combination of upper
motor neuron signs below the level of spinal cord compression
and lower motor neuron signs at the level where the nerve root
exits the stenotic spinal canal. A study by Cook et al (2010)
assessed the sensitivity and specificity of clustered examination findings, including Babinski sign, inverted supinator and
Hoffmann signs, gait dysfunction and age more than 45 years.49
Based on their results, patients who did not exhibit one of these
findings were unlikely to have cervical myelopathy (94% sensitivity). In contrast, presence of at least three of the five findings was highly specific (99%) for a diagnosis of DCM. The
benefit of considering these signs, or a similar set, in a preimaging likelihood criteria is that they are rapidly applicable
and do not necessitate extensive neurological examination that,
although desirable, may not be plausible under the real-word
time constraints PCPs must often work within. However,
although relatively straight-forward, eliciting these clinical
signs will carry a degree of inter-user variability and hence
may reduce the reliability of any criteria that is based on them.

Imaging
Cervical MRI is the gold standard for diagnosing patients with
DCM as it can identify the degree of canal stenosis, visualize
cord compression and detect intramedullary signal changes.
Unfortunately, many of these findings on MRI do not correlate
with the presence of clinical myelopathy or its severity.
Furthermore, there is great heterogeneity in specialist reporting
of MRI and hence should not be used as the sole basis for
ruling-in or ruling-out a diagnosis of DCM for non-specialists.50 However, in the correct clinical context, certain imaging
features can help confirm a diagnosis of DCM and should be
included in diagnostic criteria. For example, in a study by
Harrop et al (2010), myelopathy, defined as the presence of
>1 long-tract sign localized to the cervical spinal cord, was
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highly associated with the presence of hyperintensity on a
T2-weighted image as well as spinal cord compression (defined
as indentation of the spinal cord parenchyma changing the
contour of the spinal cord perimeter).51 One option would be
to necessitate reporting of one or more objective measures of
pathology on MRI, as calculated by a specialist radiologist to
allow objectivity in canal stenosis and cord hyperintensity.
These could then be integrated with pre-imaging likelihood
criteria to formulate post-imaging diagnostic criteria to confirm
or refute a diagnosis of DCM.

Special Considerations in Establishing Diagnostic Criteria
in DCM
Despite the apparent benefits to establishing diagnostic criteria
of DCM, there are several challenges. Due to the relative paucity of research examining the presenting symptoms and signs
of DCM, the details of initial presentation of DCM and its early
progression remain uncertain.
Although there are many classically observed signs and
symptoms of DCM (e.g. motor weakness, loss of dexterity,
sensory dysaethesia, gait disturbance, etc), recent patient interviews have uncovered a number of newly appreciated features.45 Moreover, recent MRI studies of the brain in DCM,
have started to indicate the occurrence of neurological structural and functional re-organisation, as a result of chronic
spinal cord dysfunction. These changes have the potential to
underpin functional changes, so called mal-adaptive plasticity,
which may produce clinical signs or symptoms ‘above’ the
level of the spinal cord. For example, Chen et al demonstrated
functional connectivity changes within the visual cortex of
DCM patients (N¼30), compared to healthy controls (N¼20)
which correlated with their visual acuity and negatively correlated with their JOA score.52 Hence, as more is understood of
DCM, classical presenting symptoms of DCM may need to be
re-considered and revised in any diagnostic criteria.
Therefore, it is possible that diagnostic criteria based solely
on classical symptoms and signs may not accurately reflect
patients’ early experiences and clinical presentations with
DCM to their PCPs. Furthermore, as evident in the above
review of signs and symptoms of DCM, clinical presentation
and progression of DCM is heterogeneous, especially in early
disease, and therefore any diagnostic criteria will face challenges in establishing adequate sensitivity and specificity to
ensure it is a useful tool in early detection. Additionally, many
early signs and symptoms of DCM overlap with other neurological pathologies (e.g. anterior horn cell disease presenting
with hand weakness or Parkinson’s disease presenting with gait
disturbance). This fact imposes a further challenge on diagnostic criteria to have adequate validity. Finally, numerous signs of
DCM require thorough neurological examination (e.g. Hoffmann’s reflex, Babinski reflex, subtle motor or sensory disturbance, Lhermitte’s sign, etc). If such signs were to be included
in diagnostic criteria for DCM, this would place a likely unrealistic burden on non-specialist clinicians to accurately and
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rapidly assess a patient’s neurological state using examinations
they may not routinely perform at present.
One way to address concerns with specificity and sensitivity
in early disease detections would be to use retrospective analysis to design multiple diagnostic criteria and run these in
parallel through a process of prospective validation and comparison. This would help to identify the optimal criteria as well
as shed further light on early presentations of DCM. Additionally, although the authors acknowledge the challenges associated with neurological symptom overlap of DCM with other
neurological conditions in terms of validity of pre-imaging
diagnostic likelihood criteria, we believe that inclusion of
objective MRI evidence of cord compression would reduce any
issues for criteria validity. Furthermore, if pre-imaging likelihood criteria overlap with other neurological conditions, it
may serve the unintended benefit of improving early detection
of other chronic, progressive neurological conditions and facilitate their subsequent management.

Conclusion
At present, there are no established diagnostic criteria for
DCM. Research has demonstrated that extensive delays exist
in the current diagnosis and treatment of DCM. Diagnostic
criteria with appropriate validity, reliability, and sustainability
could facilitate earlier diagnosis, specialist imaging, and surgical intervention when clinically warranted. As such, diagnostic
criteria in DCM would improve patients’ outcomes using existing treatment strategies. Moreover, a simplified checklist to
enable PCPs to effectively screen for DCM in a brief clinic
encounter would also be of value.53 The authors would advocate further work being performed to establish diagnostic
criteria through critical analysis of the literature, multidisciplinary consensus-based discussion, and consultation and
prospective validation of diagnostic approaches tailored to suit
the needs of PCPs and specialists.
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